NCT01965912
Phenylketonuria
The below information is taken directly from public registry websites such as ClinicalTrials.gov, EuClinicalTrials.eu, ISRCTN.com, etc. and has not been edited.
The study is a single-cohort, interventional, open-label trial to evaluate long-term neurocognitive (NC) outcomes in children aged 4 to 5 years with phenylketonuria (PKU) treated with Kuvan® and Phenylalanine-restricted diet over a period of 7 years.
All
4 Years to 5 Years
No
Kuvan®
Phase 4
Interventional
34
2013-10
2023-04-24
Munich, , Germany
Münster, , Germany
Bologna, , Italy
Roma, , Italy
Roma, , Italy
Barcelona, , Spain
Murcia, , Spain
Santiago de Compostela, , Spain
Birmingham, , United Kingdom
Bristol, , United Kingdom
London, , United Kingdom
London, , United Kingdom
By completing this form and clicking the send button, you understand and hereby consent to storage of your personal information, including within the United States and Europe, which will be accessible by BioMarin for purposes such as responding to your request, quality control, fulfilling compliance obligations, and assisting with products, services, or clinical trials. Depending on where you live, you may have the right to request access to, removal, or correction of your personal information held by BioMarin. You may submit your request via the contact information and/or webform located within the full BioMarin Privacy Policy.
*required fields
"*" indicates required fields